ENTITY

Biomarin Pharmaceutical (BMRN US)

57
Analysis
Health CareUnited States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
Company Presentation28 Oct 2025 04:30
Company Presentation05 Aug 2025 04:30
Company Presentation02 May 2025 04:30
Company Presentation20 Feb 2025 05:30
Company Presentation30 Oct 2024 04:30
x